Page last updated: 2024-12-08

s-adenosylhomocysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

S-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439155
CHEMBL ID418052
CHEBI ID16680
SCHEMBL ID8836
MeSH IDM0019321

Synonyms (74)

Synonym
formycinylhomocysteine
d-ribitol, 5-s-(3-amino-3-carboxypropyl)-1-c-(7-amino-1h-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-5-thio-, (1s,5(s))-
brn 5166233
s-(5'-deoxyadenosin-5'-yl)-l-homocysteine
CHEBI:16680 ,
s-[1-(adenin-9-yl)-1,5-dideoxy-beta-d-ribofuranos-5-yl]-l-homocysteine
s-(5'-adenosyl)-l-homocysteine
l-homocysteine, s-(5'-deoxyadenosin-5'-yl)-
5'-deoxy-s-adenosyl-l-homocysteine
adenosyl-l-homocysteine
homocysteine, s-adenosyl-, l- (6ci,7ci)
(s)-5'-(s)-(3-amino-3-carboxypropyl)-5'-thioadenosine
adenosine, 5'-s-(3-amino-3-carboxypropyl)-5'-thio-, l- (8ci)
l-homocysteine, s-(5'-deoxyadenosin-5'-yl)- (9ci)
adenosine, 5'-s-[(3s)-3-amino-3-carboxypropyl]-5'-thio-
l-s-adenosylhomocysteine
s-(5'-deoxyadenosine-5')-l-homocysteine
s-adenosyl-l-homocysteine
adohcy
s-adenosylhomocysteine
979-92-0
ADENOSYL-HOMO-CYS ,
2-s-adenosyl-l-homocysteine
adenosylhomocysteine
SAH ,
s-adenosyl-homocysteine
C00021
adenosylhomo-cys
s-(5'-adenosyl)-l-homocysteine, crystalline
1NW7
2BQZ
1S4D
2H23
DB01752
1QAN
1JQD
1AQI
s-adenosyl homocysteine
CHEMBL418052 ,
BMSE000289
bdbm50009672
s-(5''-adenosyl)-l-homocysteine
us8895245, s-adenosyl-l-homocysteine (sah)
s-(5''-deoxyadenosin-5''-yl)-l-homocysteine
8k31q2s66s ,
einecs 213-560-8
unii-8k31q2s66s
gtpl5265
(2s)-2-amino-4-({[(2s,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid
CCG-208703
AKOS022184395
SCHEMBL8836
s-(((2s,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-l-homocysteine
c14h20n6o5s
s-adenosyl-l-homocysteine [usp-rs]
s-adenosyl-l-homocysteine, united states pharmacopeia (usp) reference standard
AS-64957
l-5'-s-(3-amino-3-carboxypropyl)-5'-thior-adenosine
l-s-adenosyl-homocysteine
5'-s-(3-amino-3-carboxypropyl)-5'-thio-l-adenosine
CS-0015632
HY-19528
(s)-2-amino-4-(((2s,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methylthio)butanoic acid
(2s)-2-amino-4-({[(2s,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}sulfanyl)butanoic acid (non-preferred name)
NCGC00263623-02
NCGC00263623-03
DTXSID30895860
Q307434
FT-0771999
NCGC00263623-01
(s)-2-amino-4-((((2s,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid
S7868
s-adenosyl-l-homocysteine (sah)
A858597

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"When adenosine deaminase activity is inhibited, low concentrations of adenosine are toxic to human lymphoblast mutants that are unable to convert adenosine to intracellular nucleotides."( S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity.
Hershfield, MS; Krodich, NM, 1978
)
1.7
"5 rat embryos L-homocysteine was not toxic at 1- and 2-mM concentrations."( Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos.
Blom, HJ; Copius Peereboom-Stegeman, JH; Deabreu, RA; Eskes, TK; Noordhoek, J; Trijbels, FJ; Vanaerts, LA, 1994
)
0.29

Pharmacokinetics

ExcerptReferenceRelevance
" Absorption and pharmacokinetic parameters were determined in dog after oral and intravenous administration."( Pharmacokinetics and metabolism of S-adenosyl-L-homocysteine, in rats and dog.
Chabannes, B; Gharib, A; Pacheco, H; Sarda, N,
)
0.13

Bioavailability

ExcerptReferenceRelevance
"A perfusion technique was utilized to assess the rate of absorption and metabolism of L-methionine by livers isolated from rats fed a diet deficient in zinc."( Effect of zinc deficiency on methionine metabolism, methylation reactions and protein synthesis in isolated perfused rat liver.
Duerre, JA; Wallwork, JC, 1985
)
0.27
" Homocysteine levels are regulated by folate bioavailability and also by the methyl donor S-adenosylmethionine (SAM) and its metabolite S-adenosylhomocysteine (SAH)."( Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Arning, E; Bottiglieri, T; Dayal, S; Faraci, FM; Heistad, DD; Lentz, SR; Maeda, N; Malinow, MR; Sigmund, CD, 2001
)
0.78
" Since most efforts have focused on the development of nucleoside analog inhibitors, issues regarding bioavailability and selectivity have been major challenges."( A new structural class of S-adenosylhomocysteine hydrolase inhibitors.
Chun, TG; Kim, BG; Lee, HY; Snapper, ML, 2009
)
0.65
" Reduced bioavailability of nitric oxide (NO) is a principal manifestation of underlying endothelial dysfunction, which is an initial event in vascular disease."( Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.
Barroso, M; Blom, HJ; Castro, R; de Almeida, IT; Esse, R; Gomes, AQ; Gonçalves, I; Jakobs, C; Loscalzo, J; Rivera, I; Rocha, MS; Teerlink, T, 2012
)
0.38
"We investigated the effects of folate-enriched egg yolk powder on folate and homocysteine levels in plasma and liver of rats fed the folate- and choline-deficient diet to determine bioavailability in vivo."( The beneficial effect of folate-enriched egg on the folate and homocysteine levels in rats fed a folate- and choline-deficient diet.
Awaji, H; Horie, K; Kim, M; Nakata, R; Sugiyama, A, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" The lowering of epinephrine concentration was greater with L-dopa than with D-dopa, was dose-related over a dosage range of 50 to 200 mg/kg of L-dopa and was not prevented by a dopamine receptor antagonist."( Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
Fuller, RW; Hemrick-Luecke, SK; Perry, KW, 1982
)
0.47
" B6C3F1 mice were dosed dermally with DEA (0, 10, 20, 40, 80, and 160 mg/kg) for 4 weeks (5 days/week)."( Diethanolamine induces hepatic choline deficiency in mice.
Gamsky, EA; Hicks, SM; Lehman-McKeeman, LD; Mar, MH; Vassallo, JD; Zeisel, SH, 2002
)
0.31
" Subjects with normal MMA were randomly assigned to 1 of 3 dosage groups: 0, 25, or 100 microg cyanocobalamin/d."( Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment.
Allen, RH; Dolce, ET; Johnson, MA; Stabler, SP, 2006
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
cofactorAn organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitorAn EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of cyclopropane fatty acid synthase (EC 2.1.1.79).
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitorAn EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of site-specific DNA-methyltransferase (adenine-specific), EC 2.1.1.72.
fundamental metaboliteAny metabolite produced by all living cells.
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
homocysteines
adenosinesAny purine ribonucleoside that is a derivative of adenosine.
organic sulfideCompounds having the structure RSR (R =/= H). Such compounds were once called thioethers.
homocysteine derivativeA non-proteinogenic amino acid derivative resulting from reaction of homocysteine at the amino group, the carboxy group, or the side-chain amino group, or from the replacement of any hydrogen of homocysteine by a heteroatom. The definition normally excludes peptides containing homocysteine residues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (86)

PathwayProteinsCompounds
Transport of small molecules39295
SLC-mediated transmembrane transport13567
Transport of inorganic cations/anions and amino acids/oligopeptides5427
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of cofactors1947
Ubiquinol biosynthesis824
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism4485
Metabolism of proteins1058144
Nicotinate and Nicotinamide metabolism ( Nicotinate and Nicotinamide metabolism )2225
Post-translational protein modification666112
Protein methylation174
Disease1278231
Infectious disease89579
Metabolism of RNA63740
rRNA processing18610
rRNA processing in the mitochondrion102
rRNA modification in the mitochondrion62
tRNA processing10729
tRNA modification in the nucleus and cytosol4325
Synthesis of wybutosine at G37 of tRNA(Phe)616
tRNA modification in the mitochondrion95
Arginine and Proline metabolism ( Arginine and Proline metabolism )4255
Glycine and Serine metabolism ( Glycine and Serine metabolism )3649
Histidine degradation ( Histidine degradation )2326
Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )2342
Tryptophan degradation ( Tryptophan degradation )6454
Tyrosine metabolism ( Tyrosine metabolism )2841
Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics2719
SARS-CoV Infections28229
SARS-CoV-1 Infection11422
SARS-CoV-1 Genome Replication and Transcription68
Replication of the SARS-CoV-1 genome58
Transcription of SARS-CoV-1 sgRNAs27
SARS-CoV-1 Infection6019
SARS-CoV-2 Infection7720
SARS-CoV-2 Infection19527
SARS-CoV-2 Genome Replication and Transcription710
Replication of the SARS-CoV-2 genome59
Transcription of SARS-CoV-2 sgRNAs38
7q11.23 copy number variation syndrome213
Creatine pathway116
Early SARS-CoV-2 Infection Events2811
Late SARS-CoV-2 Infection Events3418
Arsenic metabolism and reactive oxygen species generation010
Viral Infection Pathways72739
Metabolic Epileptic Disorders2589
Respiratory Syncytial Virus Infection Pathway8915
Respiratory syncytial virus (RSV) genome replication, transcription and translation2513
Respiratory syncytial virus genome transcription38
superpathway of sterol biosynthesis050
ubiquinone-9 biosynthesis09
ovothiol A biosynthesis05
methionine biosynthesis020
superpathway of phospholipid biosynthesis027
ester phospholipid biosynthesis021
superpathway of lysine, threonine and methionine biosynthesis II032
methionine biosynthesis II018
S-adenosylmethionine cycle08
ubiquinone (coenzyme Q) biosynthesis026
phospholipid biosynthesis010
Methylation05
Folic acid network070
Catecholamine synthesis012
Kennedy pathway012
Folate-alcohol and cancer pathway012
One-carbon donor022
Trans-sulfuration and one-carbon metabolism020
Neurotransmitter clearance in synaptic cleft022
Vitamin B12 metabolism050
Folate-alcohol and cancer pathway hypotheses012
Folate metabolism156
Trans-sulfuration pathway014
Dopamine metabolism032
Trans-sulfuration, one-carbon metabolism and related pathways053
Glycerophospholipid biosynthetic pathway3233
Methionine de novo and salvage pathway148
Biochemical pathways: part I0466
Kennedy pathway from sphingolipids011
One-carbon metabolism and related pathways038
Ethanol effects on histone modifications017
MTHFR deficiency1515
Disorders of folate metabolism and transport1827
Vitamin B12 disorders1313
Methionine metabolism leading to sulfur amino acids and related disorders919
Methylation pathways05
vitamin K1218
Vitamin E biosynthesis514

Protein Targets (58)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Histamine N-MethyltransferaseHomo sapiens (human)Ki6.90006.90006.90006.9000AID977610
Chain A, Histamine N-MethyltransferaseHomo sapiens (human)Ki6.90006.90006.90006.9000AID977610
Chain A, Ermc' MethyltransferaseBacillus subtilisKi33.000018.000025.500033.0000AID977610
Chain A, Ermc' Rrna MethyltransferaseBacillus subtilisKi33.000018.000025.500033.0000AID977610
Chain A, Uroporphyrin-III C-methyltransferasePseudomonas denitrificans (nom. rej.)Ki0.32000.32000.32000.3200AID977610
Protein arginine N-methyltransferase 5Homo sapiens (human)IC50 (µMol)12.84000.00900.69158.6000AID1226182; AID1494590; AID1530646; AID1636912
Histone-lysine N-methyltransferase SUV39H1Homo sapiens (human)IC50 (µMol)1.20000.06600.51401.2000AID1192333
Histone-lysine N-methyltransferase SUV39H1Homo sapiens (human)Ki4.90004.90004.90004.9000AID702372
Protein arginine N-methyltransferase 3Homo sapiens (human)IC50 (µMol)0.95670.01901.29957.1000AID1636911; AID1689509; AID1689512
Indolethylamine N-methyltransferaseHomo sapiens (human)Ki2.00002.00002.00002.0000AID91847
Histone-lysine N-methyltransferase NSD2Homo sapiens (human)IC50 (µMol)39.10002.65002.65002.6500AID1767957
Phenylethanolamine N-methyltransferaseBos taurus (cattle)Ki45.65000.00312.329310.0000AID155171
Phenylethanolamine N-methyltransferaseHomo sapiens (human)Ki14.00000.00161.35296.9000AID1700192
DNA (cytosine-5)-methyltransferase 1Homo sapiens (human)IC50 (µMol)1.42120.01861.64886.0000AID1624428; AID1636910; AID1689505; AID1882663; AID424221; AID424255; AID461003; AID631010; AID657293; AID670021
Nicotinamide N-methyltransferaseHomo sapiens (human)IC50 (µMol)35.30003.62004.41005.2000AID1510774
Fatty acid synthaseHomo sapiens (human)Ki150.00000.28003.44675.9000AID71601
Histamine N-methyltransferaseHomo sapiens (human)Ki14.30000.01900.01900.0190AID90044
WD repeat-containing protein 5Homo sapiens (human)IC50 (µMol)0.72400.22302.45625.9000AID1658842
Histone-lysine N-methyltransferase 2AHomo sapiens (human)IC50 (µMol)1.51200.45002.30935.9000AID1192330; AID1658842
Histone-lysine N-methyltransferase SETDB1Homo sapiens (human)IC50 (µMol)2.20002.20002.20002.2000AID1192332
Retinoblastoma-binding protein 5Homo sapiens (human)IC50 (µMol)0.72400.72400.72400.7240AID1658842
Histone-lysine N-methyltransferase EZH2Homo sapiens (human)IC50 (µMol)24.84000.00030.50478.9000AID1192321; AID1192323; AID1636916; AID1689506; AID1868500
N6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)IC50 (µMol)0.59000.59000.59000.5900AID1829989
Histone-arginine methyltransferase CARM1Homo sapiens (human)Ki0.63000.40000.63000.8600AID1054111; AID702371
Histone-lysine N-methyltransferase KMT5CHomo sapiens (human)IC50 (µMol)10.000010.000010.000010.0000AID1192335
Histone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)IC50 (µMol)0.39000.00010.51357.0000AID1636909; AID1868496; AID738916; AID738930
Histone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)Ki0.19670.00000.06370.3000AID1054112; AID1525536; AID702374
Histone-lysine N-methyltransferase SETD7Homo sapiens (human)IC50 (µMol)38.50000.00202.52666.0800AID1192331; AID1636914
Histone-lysine N-methyltransferase EZH1Homo sapiens (human)IC50 (µMol)6.40000.00402.61658.7700AID1192326
Histone-lysine N-methyltransferase EHMT2Homo sapiens (human)IC50 (µMol)2.64000.00251.14809.2000AID1192328; AID1636913; AID1689507
Histone-lysine N-methyltransferase EHMT2Homo sapiens (human)Ki0.57000.00370.14880.5700AID1054110
Protein arginine N-methyltransferase 1Homo sapiens (human)IC50 (µMol)0.43000.25003.61679.4000AID1196391; AID1255952; AID1464544; AID1868502
Protein arginine N-methyltransferase 1Homo sapiens (human)Ki0.40000.40001.05501.7100AID702373
Methylosome protein 50Homo sapiens (human)IC50 (µMol)0.58000.02200.16880.6000AID1494590; AID1530646
Protein dpy-30 homologHomo sapiens (human)IC50 (µMol)0.72400.72400.72400.7240AID1658842
Histone-lysine N-methyltransferase EHMT1Homo sapiens (human)IC50 (µMol)0.23000.01300.79954.9000AID1192329
N-lysine methyltransferase SMYD2Homo sapiens (human)IC50 (µMol)0.18000.01500.769210.0000AID1192336
Protein arginine N-methyltransferase 7Homo sapiens (human)IC50 (µMol)25.05500.11003.80507.5000AID1226183; AID1689511
DNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)IC50 (µMol)10.29000.20001.21647.5000AID1226185; AID1882673; AID424222; AID424256; AID461004
Set1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)IC50 (µMol)0.72400.72400.72400.7240AID1658842
DNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)IC50 (µMol)50.00000.50003.733310.0000AID1226184
Non-structural protein 1 Dengue virusIC50 (µMol)0.49000.04101.32592.3000AID1631411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, ADENINE-N6-DNA-METHYLTRANSFERASE TAQIThermus aquaticusKd2.40000.34001.37002.4000AID977611
Chain A, Adenine-n6-dna-methyltransferase TaqiThermus aquaticusKd2.40000.34001.37002.4000AID977611
Chain A, Modification Methylase RsriCereibacter sphaeroidesKd8.10008.10008.10008.1000AID977611
Chain A, Modification Methylase RsriCereibacter sphaeroidesKd8.10008.10008.10008.1000AID977611
Chain B, ADENINE-N6-DNA-METHYLTRANSFERASE TAQIThermus aquaticusKd2.40000.34001.37002.4000AID977611
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenasePisum sativum (garden pea)Kd21.20004.2000341.80001,000.0000AID977611
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferasePisum sativum (garden pea)Kd21.20004.2000341.80001,000.0000AID977611
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferasePisum sativum (garden pea)Kd21.20004.2000341.80001,000.0000AID977611
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferasePisum sativum (garden pea)Kd21.20004.2000341.80001,000.0000AID977611
tRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)Kd13.60007.50007.50007.5000AID1881233
tRNA (guanine-N(1)-)-methyltransferaseStaphylococcus aureus subsp. aureus NCTC 8325Kd3.30003.30003.30003.3000AID1578014
Histone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)Kd0.25500.00030.17010.3600AID702364; AID702365
tRNA (guanine-N(1)-)-methyltransferasePseudomonas aeruginosa PAO1Kd5.90005.90005.90005.9000AID1578012
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AdenosylhomocysteinaseRattus norvegicus (Norway rat)Km9.70009.70009.70009.7000AID199294
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (260)

Processvia Protein(s)Taxonomy
tRNA methylationtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
response to amphetaminetRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
tRNA modificationtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
tRNA stabilizationtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
peptidyl-arginine N-methylationProtein arginine N-methyltransferase 5Homo sapiens (human)
spliceosomal snRNP assemblyProtein arginine N-methyltransferase 5Homo sapiens (human)
chromatin remodelingProtein arginine N-methyltransferase 5Homo sapiens (human)
DNA-templated transcription terminationProtein arginine N-methyltransferase 5Homo sapiens (human)
regulation of mitotic nuclear divisionProtein arginine N-methyltransferase 5Homo sapiens (human)
peptidyl-arginine methylationProtein arginine N-methyltransferase 5Homo sapiens (human)
circadian regulation of gene expressionProtein arginine N-methyltransferase 5Homo sapiens (human)
endothelial cell activationProtein arginine N-methyltransferase 5Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationProtein arginine N-methyltransferase 5Homo sapiens (human)
negative regulation of cell differentiationProtein arginine N-methyltransferase 5Homo sapiens (human)
negative regulation of DNA-templated transcriptionProtein arginine N-methyltransferase 5Homo sapiens (human)
positive regulation of mRNA splicing, via spliceosomeProtein arginine N-methyltransferase 5Homo sapiens (human)
positive regulation of oligodendrocyte differentiationProtein arginine N-methyltransferase 5Homo sapiens (human)
regulation of ERK1 and ERK2 cascadeProtein arginine N-methyltransferase 5Homo sapiens (human)
Golgi ribbon formationProtein arginine N-methyltransferase 5Homo sapiens (human)
liver regenerationProtein arginine N-methyltransferase 5Homo sapiens (human)
regulation of signal transduction by p53 class mediatorProtein arginine N-methyltransferase 5Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathwayProtein arginine N-methyltransferase 5Homo sapiens (human)
regulation of DNA-templated transcriptionProtein arginine N-methyltransferase 5Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
DNA damage responseHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cellular response to hypoxiaHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rDNA heterochromatin formationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rRNA processingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
circadian rhythmHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cell differentiationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
methylationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cellular response to glucose starvationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
epigenetic programming in the zygotic pronucleiHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
negative regulation of cell cycleHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
regulation of transcription by glucoseHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
energy homeostasisHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
negative regulation of protein ubiquitinationProtein arginine N-methyltransferase 3Homo sapiens (human)
methylationProtein arginine N-methyltransferase 3Homo sapiens (human)
negative regulation of retinoic acid biosynthetic processProtein arginine N-methyltransferase 3Homo sapiens (human)
peptidyl-arginine methylation, to asymmetrical-dimethyl arginineProtein arginine N-methyltransferase 3Homo sapiens (human)
chromatin remodelingProtein arginine N-methyltransferase 3Homo sapiens (human)
protein methylationProtein arginine N-methyltransferase 3Homo sapiens (human)
amine metabolic processIndolethylamine N-methyltransferaseHomo sapiens (human)
response to toxic substanceIndolethylamine N-methyltransferaseHomo sapiens (human)
methylationIndolethylamine N-methyltransferaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
membranous septum morphogenesisHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
atrial septum primum morphogenesisHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
atrial septum secundum morphogenesisHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
double-strand break repairHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
methylationHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
positive regulation of isotype switching to IgA isotypesHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
bone developmentHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
regulation of establishment of protein localizationHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
regulation of double-strand break repair via nonhomologous end joiningHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
methylationPhenylethanolamine N-methyltransferaseHomo sapiens (human)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
catecholamine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA methylation-dependent heterochromatin formationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA-templated transcriptionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
positive regulation of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
methylationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
epigenetic programming of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
cellular response to amino acid stimulusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
chromosomal DNA methylation maintenance following DNA replicationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
cellular response to bisphenol ADNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell apoptotic processDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switchingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nicotinamide metabolic processNicotinamide N-methyltransferaseHomo sapiens (human)
response to xenobiotic stimulusNicotinamide N-methyltransferaseHomo sapiens (human)
response to organonitrogen compoundNicotinamide N-methyltransferaseHomo sapiens (human)
animal organ regenerationNicotinamide N-methyltransferaseHomo sapiens (human)
methylationNicotinamide N-methyltransferaseHomo sapiens (human)
NAD biosynthesis via nicotinamide riboside salvage pathwayNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of gluconeogenesisNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of protein deacetylationNicotinamide N-methyltransferaseHomo sapiens (human)
osteoblast differentiationFatty acid synthaseHomo sapiens (human)
glandular epithelial cell developmentFatty acid synthaseHomo sapiens (human)
fatty acid metabolic processFatty acid synthaseHomo sapiens (human)
fatty acid biosynthetic processFatty acid synthaseHomo sapiens (human)
inflammatory responseFatty acid synthaseHomo sapiens (human)
ether lipid biosynthetic processFatty acid synthaseHomo sapiens (human)
neutrophil differentiationFatty acid synthaseHomo sapiens (human)
monocyte differentiationFatty acid synthaseHomo sapiens (human)
mammary gland developmentFatty acid synthaseHomo sapiens (human)
modulation by host of viral processFatty acid synthaseHomo sapiens (human)
cellular response to interleukin-4Fatty acid synthaseHomo sapiens (human)
establishment of endothelial intestinal barrierFatty acid synthaseHomo sapiens (human)
fatty-acyl-CoA biosynthetic processFatty acid synthaseHomo sapiens (human)
histamine metabolic processHistamine N-methyltransferaseHomo sapiens (human)
histamine catabolic processHistamine N-methyltransferaseHomo sapiens (human)
histidine catabolic processHistamine N-methyltransferaseHomo sapiens (human)
respiratory gaseous exchange by respiratory systemHistamine N-methyltransferaseHomo sapiens (human)
methylationHistamine N-methyltransferaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIWD repeat-containing protein 5Homo sapiens (human)
skeletal system developmentWD repeat-containing protein 5Homo sapiens (human)
gluconeogenesisWD repeat-containing protein 5Homo sapiens (human)
regulation of DNA-templated transcriptionWD repeat-containing protein 5Homo sapiens (human)
regulation of transcription by RNA polymerase IIWD repeat-containing protein 5Homo sapiens (human)
positive regulation of gluconeogenesisWD repeat-containing protein 5Homo sapiens (human)
transcription initiation-coupled chromatin remodelingWD repeat-containing protein 5Homo sapiens (human)
positive regulation of DNA-templated transcriptionWD repeat-containing protein 5Homo sapiens (human)
regulation of embryonic developmentWD repeat-containing protein 5Homo sapiens (human)
regulation of cell divisionWD repeat-containing protein 5Homo sapiens (human)
regulation of cell cycleWD repeat-containing protein 5Homo sapiens (human)
regulation of tubulin deacetylationWD repeat-containing protein 5Homo sapiens (human)
apoptotic processHistone-lysine N-methyltransferase 2AHomo sapiens (human)
visual learningHistone-lysine N-methyltransferase 2AHomo sapiens (human)
post-embryonic developmentHistone-lysine N-methyltransferase 2AHomo sapiens (human)
anterior/posterior pattern specificationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
methylationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
circadian regulation of gene expressionHistone-lysine N-methyltransferase 2AHomo sapiens (human)
embryonic hemopoiesisHistone-lysine N-methyltransferase 2AHomo sapiens (human)
exploration behaviorHistone-lysine N-methyltransferase 2AHomo sapiens (human)
response to potassium ionHistone-lysine N-methyltransferase 2AHomo sapiens (human)
protein modification processHistone-lysine N-methyltransferase 2AHomo sapiens (human)
T-helper 2 cell differentiationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase 2AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase 2AHomo sapiens (human)
fibroblast proliferationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
negative regulation of fibroblast proliferationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
regulation of short-term neuronal synaptic plasticityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
spleen developmentHistone-lysine N-methyltransferase 2AHomo sapiens (human)
homeostasis of number of cells within a tissueHistone-lysine N-methyltransferase 2AHomo sapiens (human)
membrane depolarizationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
definitive hemopoiesisHistone-lysine N-methyltransferase 2AHomo sapiens (human)
protein-containing complex assemblyHistone-lysine N-methyltransferase 2AHomo sapiens (human)
cellular response to transforming growth factor beta stimulusHistone-lysine N-methyltransferase 2AHomo sapiens (human)
negative regulation of DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase 2AHomo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
methylationHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
negative regulation of single stranded viral RNA replication via double stranded DNA intermediateHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
positive regulation of DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
negative regulation of gene expressionHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
heterochromatin organizationHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
retrotransposon silencing by heterochromatin formationHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
DNA damage responseRetinoblastoma-binding protein 5Homo sapiens (human)
response to estrogenRetinoblastoma-binding protein 5Homo sapiens (human)
transcription initiation-coupled chromatin remodelingRetinoblastoma-binding protein 5Homo sapiens (human)
G1/S transition of mitotic cell cycleHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of cell population proliferationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
regulation of gliogenesisHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
skeletal muscle satellite cell maintenance involved in skeletal muscle regenerationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
cardiac muscle hypertrophy in response to stressHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
cerebellar cortex developmentHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
hippocampus developmentHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
B cell differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
keratinocyte differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of cell migrationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
regulatory ncRNA-mediated heterochromatin formationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
subtelomeric heterochromatin formationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
methylationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
response to estradiolHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of transcription elongation by RNA polymerase IIHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
cellular response to trichostatin AHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
protein modification processHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
hepatocyte homeostasisHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
regulation of circadian rhythmHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of MAP kinase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of GTPase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of keratinocyte differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of gene expression, epigeneticHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of retinoic acid receptor signaling pathwayHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
rhythmic processHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
stem cell differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of striated muscle cell differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
synaptic transmission, GABAergicHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
cellular response to hydrogen peroxideHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
G1 to G0 transitionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
protein localization to chromatinHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of protein serine/threonine kinase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
regulation of kidney developmentHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
liver regenerationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
facultative heterochromatin formationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of dendrite developmentHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
positive regulation of cell cycle G1/S phase transitionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
response to tetrachloromethaneHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of G1/S transition of mitotic cell cycleHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
negative regulation of stem cell differentiationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
heterochromatin formationHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
mRNA splicing, via spliceosomeN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA splicing, via spliceosomeN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
RNA methylationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA processingN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
DNA damage responseN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
spermatogenesisN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
circadian rhythmN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
dosage compensation by inactivation of X chromosomeN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA modificationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
stem cell population maintenanceN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
forebrain radial glial cell differentiationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
primary miRNA processingN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
cellular response to UVN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
gliogenesisN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
innate immune responseN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
regulation of T cell differentiationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
positive regulation of translationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
negative regulation of Notch signaling pathwayN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
oogenesisN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
regulation of meiotic cell cycleN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA destabilizationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
endothelial to hematopoietic transitionN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
regulation of hematopoietic stem cell differentiationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
positive regulation of cap-independent translational initiationN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
regulation of DNA-templated transcriptionHistone-arginine methyltransferase CARM1Homo sapiens (human)
positive regulation of cell population proliferationHistone-arginine methyltransferase CARM1Homo sapiens (human)
methylationHistone-arginine methyltransferase CARM1Homo sapiens (human)
regulation of intracellular estrogen receptor signaling pathwayHistone-arginine methyltransferase CARM1Homo sapiens (human)
positive regulation of fat cell differentiationHistone-arginine methyltransferase CARM1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IHistone-arginine methyltransferase CARM1Homo sapiens (human)
response to cAMPHistone-arginine methyltransferase CARM1Homo sapiens (human)
replication fork reversalHistone-arginine methyltransferase CARM1Homo sapiens (human)
positive regulation of epithelial cell apoptotic processHistone-arginine methyltransferase CARM1Homo sapiens (human)
negative regulation of dendrite developmentHistone-arginine methyltransferase CARM1Homo sapiens (human)
peptidyl-arginine methylation, to asymmetrical-dimethyl arginineHistone-arginine methyltransferase CARM1Homo sapiens (human)
chromatin remodelingHistone-arginine methyltransferase CARM1Homo sapiens (human)
DNA repairHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
methylationHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
positive regulation of isotype switchingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
positive regulation of double-strand break repair via nonhomologous end joiningHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
positive regulation of cell population proliferationHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
gene expressionHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
heterochromatin formationHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
telomere organizationHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
methylationHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
regulation of receptor signaling pathway via JAK-STATHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
regulation of transcription regulatory region DNA bindingHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
DNA repairHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
DNA damage checkpoint signalingHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
DNA damage responseHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
heterochromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
peptidyl-lysine monomethylationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
response to ethanolHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
heterochromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
anatomical structure morphogenesisHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
hippocampus developmentHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
heterochromatin formationHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
subtelomeric heterochromatin formationHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
methylationHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to starvationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of DNA replicationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
synaptonemal complex assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
spermatid developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
long-term memoryHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
fertilizationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of protein modification processHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
organ growthHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
phenotypic switchingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to ethanolHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
behavioral response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
oocyte developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
neuron fate specificationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to fungicideHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to xenobiotic stimulusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of autophagosome assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
in utero embryonic developmentProtein arginine N-methyltransferase 1Homo sapiens (human)
protein methylationProtein arginine N-methyltransferase 1Homo sapiens (human)
DNA damage responseProtein arginine N-methyltransferase 1Homo sapiens (human)
cell surface receptor signaling pathwayProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of cell population proliferationProtein arginine N-methyltransferase 1Homo sapiens (human)
RNA splicingProtein arginine N-methyltransferase 1Homo sapiens (human)
peptidyl-arginine methylationProtein arginine N-methyltransferase 1Homo sapiens (human)
viral protein processingProtein arginine N-methyltransferase 1Homo sapiens (human)
regulation of BMP signaling pathwayProtein arginine N-methyltransferase 1Homo sapiens (human)
neuron projection developmentProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of erythrocyte differentiationProtein arginine N-methyltransferase 1Homo sapiens (human)
regulation of megakaryocyte differentiationProtein arginine N-methyltransferase 1Homo sapiens (human)
negative regulation of megakaryocyte differentiationProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of translationProtein arginine N-methyltransferase 1Homo sapiens (human)
negative regulation of JNK cascadeProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of hemoglobin biosynthetic processProtein arginine N-methyltransferase 1Homo sapiens (human)
cardiac muscle tissue developmentProtein arginine N-methyltransferase 1Homo sapiens (human)
protein homooligomerizationProtein arginine N-methyltransferase 1Homo sapiens (human)
cellular response to methionineProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of p38MAPK cascadeProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of TORC1 signalingProtein arginine N-methyltransferase 1Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationProtein arginine N-methyltransferase 1Homo sapiens (human)
chromatin remodelingProtein arginine N-methyltransferase 1Homo sapiens (human)
peptidyl-arginine methylation, to asymmetrical-dimethyl arginineProtein arginine N-methyltransferase 1Homo sapiens (human)
protein polyubiquitinationMethylosome protein 50Homo sapiens (human)
spliceosomal snRNP assemblyMethylosome protein 50Homo sapiens (human)
regulation of transcription by RNA polymerase IIMethylosome protein 50Homo sapiens (human)
ubiquitin-dependent protein catabolic processMethylosome protein 50Homo sapiens (human)
positive regulation of cell population proliferationMethylosome protein 50Homo sapiens (human)
positive regulation of DNA-templated transcriptionMethylosome protein 50Homo sapiens (human)
positive regulation of mRNA splicing, via spliceosomeMethylosome protein 50Homo sapiens (human)
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus developmentMethylosome protein 50Homo sapiens (human)
epithelial cell proliferation involved in prostate gland developmentMethylosome protein 50Homo sapiens (human)
negative regulation of epithelial cell proliferation involved in prostate gland developmentMethylosome protein 50Homo sapiens (human)
oocyte axis specificationMethylosome protein 50Homo sapiens (human)
endosomal transportProtein dpy-30 homologHomo sapiens (human)
transcription initiation-coupled chromatin remodelingProtein dpy-30 homologHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
cellular response to hypoxiaHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
circadian rhythmHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
cell differentiationHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
methylationHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
epigenetic programming in the zygotic pronucleiHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
negative regulation of gene expression, epigeneticHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
peptidyl-lysine monomethylationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
regulation of embryonic developmentHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
response to fungicideHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
positive regulation of cold-induced thermogenesisHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIN-lysine methyltransferase SMYD2Homo sapiens (human)
chromatin remodelingN-lysine methyltransferase SMYD2Homo sapiens (human)
heart developmentN-lysine methyltransferase SMYD2Homo sapiens (human)
negative regulation of cell population proliferationN-lysine methyltransferase SMYD2Homo sapiens (human)
peptidyl-lysine monomethylationN-lysine methyltransferase SMYD2Homo sapiens (human)
peptidyl-lysine dimethylationN-lysine methyltransferase SMYD2Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorN-lysine methyltransferase SMYD2Homo sapiens (human)
regulation of signal transduction by p53 class mediatorN-lysine methyltransferase SMYD2Homo sapiens (human)
spliceosomal snRNP assemblyProtein arginine N-methyltransferase 7Homo sapiens (human)
peptidyl-arginine methylationProtein arginine N-methyltransferase 7Homo sapiens (human)
regulation of protein bindingProtein arginine N-methyltransferase 7Homo sapiens (human)
genomic imprintingProtein arginine N-methyltransferase 7Homo sapiens (human)
chromatin remodelingProtein arginine N-methyltransferase 7Homo sapiens (human)
peptidyl-arginine methylation, to asymmetrical-dimethyl arginineProtein arginine N-methyltransferase 7Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
positive regulation of gene expressionDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
methylationDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
DNA damage responseSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
positive regulation of cell population proliferationSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
hemopoiesisSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
response to estrogenSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
transcription initiation-coupled chromatin remodelingSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
DNA methylation-dependent heterochromatin formationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
spermatogenesisDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to xenobiotic stimulusDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to toxic substanceDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to ionizing radiationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to lead ionDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
neuron differentiationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
regulatory ncRNA-mediated heterochromatin formationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
methylationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to estradiolDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to vitamin ADNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
response to cocaineDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
S-adenosylmethionine metabolic processDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cellular response to amino acid stimulusDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cellular response to ethanolDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cellular response to hypoxiaDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
hepatocyte apoptotic processDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
autosome genomic imprintingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
positive regulation of cellular response to hypoxiaDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cellular response to bisphenol ADNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
negative regulation of DNA-templated transcriptionDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (112)

Processvia Protein(s)Taxonomy
RNA bindingtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
tRNA methyltransferase activitytRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
tRNA (cytidine-5-)-methyltransferase activitytRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
p53 bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
transcription corepressor activityProtein arginine N-methyltransferase 5Homo sapiens (human)
protein bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
methyl-CpG bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
protein-arginine N-methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
protein-arginine omega-N symmetric methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
histone methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
identical protein bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
ribonucleoprotein complex bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
histone H4R3 methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
protein heterodimerization activityProtein arginine N-methyltransferase 5Homo sapiens (human)
E-box bindingProtein arginine N-methyltransferase 5Homo sapiens (human)
histone H3 methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
histone arginine N-methyltransferase activityProtein arginine N-methyltransferase 5Homo sapiens (human)
transcription cis-regulatory region bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
S-adenosylmethionine-dependent methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3K9 trimethyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
protein bindingProtein arginine N-methyltransferase 3Homo sapiens (human)
methyltransferase activityProtein arginine N-methyltransferase 3Homo sapiens (human)
protein-arginine N-methyltransferase activityProtein arginine N-methyltransferase 3Homo sapiens (human)
protein-arginine omega-N monomethyltransferase activityProtein arginine N-methyltransferase 3Homo sapiens (human)
protein-arginine omega-N asymmetric methyltransferase activityProtein arginine N-methyltransferase 3Homo sapiens (human)
ribosome bindingProtein arginine N-methyltransferase 3Homo sapiens (human)
metal ion bindingProtein arginine N-methyltransferase 3Homo sapiens (human)
histone methyltransferase activityProtein arginine N-methyltransferase 3Homo sapiens (human)
thioether S-methyltransferase activityIndolethylamine N-methyltransferaseHomo sapiens (human)
protein bindingIndolethylamine N-methyltransferaseHomo sapiens (human)
amine N-methyltransferase activityIndolethylamine N-methyltransferaseHomo sapiens (human)
S-adenosyl-L-methionine:beta-alanine N-methyltransferase activityIndolethylamine N-methyltransferaseHomo sapiens (human)
N-methyltransferase activityIndolethylamine N-methyltransferaseHomo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
histone H4K20 methyltransferase activityHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
sequence-specific DNA bindingHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
metal ion bindingHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
histone H3K36 methyltransferase activityHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
histone H3K36 dimethyltransferase activityHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
histone H3K36 trimethyltransferase activityHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
adenosylselenohomocysteinase activityAdenosylhomocysteinaseRattus norvegicus (Norway rat)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseHomo sapiens (human)
protein bindingPhenylethanolamine N-methyltransferaseHomo sapiens (human)
DNA bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
RNA bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA (cytosine-5-)-methyltransferase activityDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
protein bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
zinc ion bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
methyl-CpG bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA-methyltransferase activityDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
promoter-specific chromatin bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nicotinamide N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
pyridine N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
RNA bindingFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-acetyltransferase activityFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-malonyltransferase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] synthase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
protein bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
fatty acyl-[ACP] hydrolase activityFatty acid synthaseHomo sapiens (human)
phosphopantetheine bindingFatty acid synthaseHomo sapiens (human)
cadherin bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
enoyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
fatty acid synthase activityFatty acid synthaseHomo sapiens (human)
histamine N-methyltransferase activityHistamine N-methyltransferaseHomo sapiens (human)
protein bindingWD repeat-containing protein 5Homo sapiens (human)
methylated histone bindingWD repeat-containing protein 5Homo sapiens (human)
histone H3K4 methyltransferase activityWD repeat-containing protein 5Homo sapiens (human)
histone bindingWD repeat-containing protein 5Homo sapiens (human)
minor groove of adenine-thymine-rich DNA bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
protein bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
histone H3K4 methyltransferase activityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
identical protein bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
protein homodimerization activityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
unmethylated CpG bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
lysine-acetylated histone bindingHistone-lysine N-methyltransferase 2AHomo sapiens (human)
protein-cysteine methyltransferase activityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
histone H3K4 monomethyltransferase activityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
histone H3K4 trimethyltransferase activityHistone-lysine N-methyltransferase 2AHomo sapiens (human)
DNA bindingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
histone H3K9 monomethyltransferase activityHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
histone H3K9 trimethyltransferase activityHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
promoter-specific chromatin bindingHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
transcription cis-regulatory region bindingRetinoblastoma-binding protein 5Homo sapiens (human)
protein bindingRetinoblastoma-binding protein 5Homo sapiens (human)
histone bindingRetinoblastoma-binding protein 5Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
transcription corepressor activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromatin DNA bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
ribonucleoprotein complex bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
primary miRNA bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
lncRNA bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
histone H3K27 trimethyltransferase activityHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
promoter-specific chromatin bindingHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
mRNA m(6)A methyltransferase activityN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA bindingN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
protein bindingN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
RNA methyltransferase activityN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
mRNA (2'-O-methyladenosine-N6-)-methyltransferase activityN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
protein heterodimerization activityN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
S-adenosyl-L-methionine bindingN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
transcription cis-regulatory region bindingHistone-arginine methyltransferase CARM1Homo sapiens (human)
transcription coactivator activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
protein bindingHistone-arginine methyltransferase CARM1Homo sapiens (human)
beta-catenin bindingHistone-arginine methyltransferase CARM1Homo sapiens (human)
protein methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
histone arginine N-methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
protein-arginine N-methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
nuclear receptor coactivator activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
protein-arginine omega-N asymmetric methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
histone H3R17 methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
histone methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
lysine-acetylated histone bindingHistone-arginine methyltransferase CARM1Homo sapiens (human)
histone H3R2 methyltransferase activityHistone-arginine methyltransferase CARM1Homo sapiens (human)
DNA-binding transcription factor bindingHistone-arginine methyltransferase CARM1Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
protein bindingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
histone bindingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
histone H4K20 methyltransferase activityHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
metal ion bindingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
histone H4 methyltransferase activityHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
histone H4K20me methyltransferase activityHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
histone H4K20 monomethyltransferase activityHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
S-adenosyl-L-methionine bindingHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
nucleic acid bindingHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
DNA bindingHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
protein bindingHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
histone H3K79 trimethyltransferase activityHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
histone H3K79 methyltransferase activityHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone H3K4 monomethyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
DNA bindingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
histone bindingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
transcription corepressor activityHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
nucleosome bindingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
molecular condensate scaffold activityHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
histone H3K27 trimethyltransferase activityHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
enzyme bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
C2H2 zinc finger domain bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K56 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
promoter-specific chromatin bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
RNA bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
protein bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
N-methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
protein methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
methyl-CpG bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
protein-arginine N-methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
enzyme bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
protein-arginine omega-N monomethyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
protein-arginine omega-N asymmetric methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
histone methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
identical protein bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
histone H4R3 methyltransferase activityProtein arginine N-methyltransferase 1Homo sapiens (human)
mitogen-activated protein kinase p38 bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
GATOR1 complex bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
S-adenosyl-L-methionine bindingProtein arginine N-methyltransferase 1Homo sapiens (human)
protein bindingMethylosome protein 50Homo sapiens (human)
methyl-CpG bindingMethylosome protein 50Homo sapiens (human)
nuclear receptor coactivator activityMethylosome protein 50Homo sapiens (human)
ubiquitin-like ligase-substrate adaptor activityMethylosome protein 50Homo sapiens (human)
protein bindingProtein dpy-30 homologHomo sapiens (human)
identical protein bindingProtein dpy-30 homologHomo sapiens (human)
protein homodimerization activityProtein dpy-30 homologHomo sapiens (human)
transcription cis-regulatory region bindingHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
histone H3K9 trimethyltransferase activityHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
S-adenosyl-L-methionine bindingHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
ubiquitin-like ligase-substrate adaptor activityHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
C2H2 zinc finger domain bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
RNA polymerase II complex bindingN-lysine methyltransferase SMYD2Homo sapiens (human)
p53 bindingN-lysine methyltransferase SMYD2Homo sapiens (human)
protein bindingN-lysine methyltransferase SMYD2Homo sapiens (human)
lysine N-methyltransferase activityN-lysine methyltransferase SMYD2Homo sapiens (human)
protein-lysine N-methyltransferase activityN-lysine methyltransferase SMYD2Homo sapiens (human)
metal ion bindingN-lysine methyltransferase SMYD2Homo sapiens (human)
histone H3K36 methyltransferase activityN-lysine methyltransferase SMYD2Homo sapiens (human)
histone H3 methyltransferase activityN-lysine methyltransferase SMYD2Homo sapiens (human)
histone H3K4 trimethyltransferase activityN-lysine methyltransferase SMYD2Homo sapiens (human)
protein bindingProtein arginine N-methyltransferase 7Homo sapiens (human)
S-adenosylmethionine-dependent methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
protein-arginine omega-N monomethyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
protein-arginine omega-N symmetric methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
histone bindingProtein arginine N-methyltransferase 7Homo sapiens (human)
ribonucleoprotein complex bindingProtein arginine N-methyltransferase 7Homo sapiens (human)
histone H4R3 methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
histone H4 methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
histone methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
protein-arginine N-methyltransferase activityProtein arginine N-methyltransferase 7Homo sapiens (human)
transcription corepressor activityDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
DNA (cytosine-5-)-methyltransferase activityDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
protein bindingDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
DNA-methyltransferase activityDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
metal ion bindingDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
DNA (cytosine-5-)-methyltransferase activity, acting on CpG substratesDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
DNA bindingDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
transcription cis-regulatory region bindingSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
protein bindingSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
beta-catenin bindingSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
metal ion bindingSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
DNA bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
chromatin bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
transcription corepressor activityDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
DNA (cytosine-5-)-methyltransferase activityDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
protein bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
identical protein bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
unmethylated CpG bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
metal ion bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
lncRNA bindingDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
protein-cysteine methyltransferase activityDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (54)

Processvia Protein(s)Taxonomy
nucleoplasmtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
cytoplasmtRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
nucleustRNA (cytosine(38)-C(5))-methyltransferaseHomo sapiens (human)
nucleusProtein arginine N-methyltransferase 5Homo sapiens (human)
nucleoplasmProtein arginine N-methyltransferase 5Homo sapiens (human)
Golgi apparatusProtein arginine N-methyltransferase 5Homo sapiens (human)
cytosolProtein arginine N-methyltransferase 5Homo sapiens (human)
methylosomeProtein arginine N-methyltransferase 5Homo sapiens (human)
chromatinProtein arginine N-methyltransferase 5Homo sapiens (human)
cytoplasmProtein arginine N-methyltransferase 5Homo sapiens (human)
histone methyltransferase complexProtein arginine N-methyltransferase 5Homo sapiens (human)
cytosolProtein arginine N-methyltransferase 5Homo sapiens (human)
nucleusProtein arginine N-methyltransferase 5Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromosome, centromeric regionHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
condensed nuclear chromosomeHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nuclear laminaHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleolusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
plasma membraneHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cytoplasmic vesicleHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
eNoSc complexHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
heterochromatinHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin silencing complexHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rDNA heterochromatinHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cytoplasmProtein arginine N-methyltransferase 3Homo sapiens (human)
cytosolProtein arginine N-methyltransferase 3Homo sapiens (human)
nucleusProtein arginine N-methyltransferase 3Homo sapiens (human)
cytosolIndolethylamine N-methyltransferaseHomo sapiens (human)
cytosolIndolethylamine N-methyltransferaseHomo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
nucleolusHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
cytoplasmHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase NSD2Homo sapiens (human)
cytosolAdenosylhomocysteinaseRattus norvegicus (Norway rat)
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
female germ cell nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleoplasmDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
replication forkDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
pericentric heterochromatinDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
Golgi apparatusFatty acid synthaseHomo sapiens (human)
cytosolFatty acid synthaseHomo sapiens (human)
plasma membraneFatty acid synthaseHomo sapiens (human)
membraneFatty acid synthaseHomo sapiens (human)
melanosomeFatty acid synthaseHomo sapiens (human)
glycogen granuleFatty acid synthaseHomo sapiens (human)
extracellular exosomeFatty acid synthaseHomo sapiens (human)
cytoplasmFatty acid synthaseHomo sapiens (human)
cytosolHistamine N-methyltransferaseHomo sapiens (human)
nucleoplasmHistamine N-methyltransferaseHomo sapiens (human)
cytoplasmHistamine N-methyltransferaseHomo sapiens (human)
centrosomeHistamine N-methyltransferaseHomo sapiens (human)
cytosolHistamine N-methyltransferaseHomo sapiens (human)
extracellular exosomeHistamine N-methyltransferaseHomo sapiens (human)
nucleusWD repeat-containing protein 5Homo sapiens (human)
nucleoplasmWD repeat-containing protein 5Homo sapiens (human)
NSL complexWD repeat-containing protein 5Homo sapiens (human)
MLL1/2 complexWD repeat-containing protein 5Homo sapiens (human)
MLL3/4 complexWD repeat-containing protein 5Homo sapiens (human)
Set1C/COMPASS complexWD repeat-containing protein 5Homo sapiens (human)
MLL1 complexWD repeat-containing protein 5Homo sapiens (human)
mitotic spindleWD repeat-containing protein 5Homo sapiens (human)
ATAC complexWD repeat-containing protein 5Homo sapiens (human)
histone acetyltransferase complexWD repeat-containing protein 5Homo sapiens (human)
histone methyltransferase complexWD repeat-containing protein 5Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase 2AHomo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase 2AHomo sapiens (human)
cytosolHistone-lysine N-methyltransferase 2AHomo sapiens (human)
MLL1 complexHistone-lysine N-methyltransferase 2AHomo sapiens (human)
histone methyltransferase complexHistone-lysine N-methyltransferase 2AHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
cytoplasmHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
intracellular membrane-bounded organelleHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SETDB1Homo sapiens (human)
nucleusRetinoblastoma-binding protein 5Homo sapiens (human)
nucleoplasmRetinoblastoma-binding protein 5Homo sapiens (human)
nucleolusRetinoblastoma-binding protein 5Homo sapiens (human)
MLL1/2 complexRetinoblastoma-binding protein 5Homo sapiens (human)
MLL3/4 complexRetinoblastoma-binding protein 5Homo sapiens (human)
Set1C/COMPASS complexRetinoblastoma-binding protein 5Homo sapiens (human)
MLL1 complexRetinoblastoma-binding protein 5Homo sapiens (human)
histone methyltransferase complexRetinoblastoma-binding protein 5Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromosome, telomeric regionHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
pronucleusHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
synapseHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
chromatin silencing complexHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
pericentric heterochromatinHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
ESC/E(Z) complexHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EZH2Homo sapiens (human)
nucleusN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
nucleoplasmN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
Golgi apparatusN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
cytosolN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
nuclear bodyN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
nuclear speckN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
RNA N6-methyladenosine methyltransferase complexN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
nucleusN6-adenosine-methyltransferase catalytic subunitHomo sapiens (human)
nuclear replication forkHistone-arginine methyltransferase CARM1Homo sapiens (human)
nucleusHistone-arginine methyltransferase CARM1Homo sapiens (human)
nucleoplasmHistone-arginine methyltransferase CARM1Homo sapiens (human)
cytoplasmHistone-arginine methyltransferase CARM1Homo sapiens (human)
cytosolHistone-arginine methyltransferase CARM1Homo sapiens (human)
condensed chromosome, centromeric regionHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
heterochromatinHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
pericentric heterochromatinHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase KMT5CHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
cytoplasmHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
intracellular membrane-bounded organelleHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
protein-containing complexHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
nucleolusHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromosome, telomeric regionHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
heterochromatinHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
ESC/E(Z) complexHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EZH1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nuclear speckHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
lysosomal membraneProtein arginine N-methyltransferase 1Homo sapiens (human)
nucleusProtein arginine N-methyltransferase 1Homo sapiens (human)
nucleoplasmProtein arginine N-methyltransferase 1Homo sapiens (human)
cytoplasmProtein arginine N-methyltransferase 1Homo sapiens (human)
cytosolProtein arginine N-methyltransferase 1Homo sapiens (human)
methylosomeProtein arginine N-methyltransferase 1Homo sapiens (human)
nucleusProtein arginine N-methyltransferase 1Homo sapiens (human)
nucleusMethylosome protein 50Homo sapiens (human)
nucleoplasmMethylosome protein 50Homo sapiens (human)
cytoplasmMethylosome protein 50Homo sapiens (human)
Golgi apparatusMethylosome protein 50Homo sapiens (human)
cytosolMethylosome protein 50Homo sapiens (human)
methylosomeMethylosome protein 50Homo sapiens (human)
Cul4B-RING E3 ubiquitin ligase complexMethylosome protein 50Homo sapiens (human)
nucleusProtein dpy-30 homologHomo sapiens (human)
nucleoplasmProtein dpy-30 homologHomo sapiens (human)
Golgi apparatusProtein dpy-30 homologHomo sapiens (human)
trans-Golgi networkProtein dpy-30 homologHomo sapiens (human)
MLL1/2 complexProtein dpy-30 homologHomo sapiens (human)
MLL3/4 complexProtein dpy-30 homologHomo sapiens (human)
Set1C/COMPASS complexProtein dpy-30 homologHomo sapiens (human)
MLL1 complexProtein dpy-30 homologHomo sapiens (human)
histone methyltransferase complexProtein dpy-30 homologHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
chromosome, centromeric regionHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase SUV39H2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nuclear bodyHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nucleusN-lysine methyltransferase SMYD2Homo sapiens (human)
nucleoplasmN-lysine methyltransferase SMYD2Homo sapiens (human)
cytoplasmN-lysine methyltransferase SMYD2Homo sapiens (human)
cytosolN-lysine methyltransferase SMYD2Homo sapiens (human)
nucleusN-lysine methyltransferase SMYD2Homo sapiens (human)
fibrillar centerProtein arginine N-methyltransferase 7Homo sapiens (human)
nucleusProtein arginine N-methyltransferase 7Homo sapiens (human)
nucleoplasmProtein arginine N-methyltransferase 7Homo sapiens (human)
cytosolProtein arginine N-methyltransferase 7Homo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
nucleoplasmDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
catalytic complexDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 3BHomo sapiens (human)
nucleusSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
nucleoplasmSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
MLL1/2 complexSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
MLL3/4 complexSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
Set1C/COMPASS complexSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
MLL1 complexSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
euchromatinSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
histone methyltransferase complexSet1/Ash2 histone methyltransferase complex subunit ASH2Homo sapiens (human)
chromosome, centromeric regionDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
XY bodyDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
nucleoplasmDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cytoplasmDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
nuclear matrixDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
catalytic complexDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
euchromatinDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
heterochromatinDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
cytoplasmDNA (cytosine-5)-methyltransferase 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (190)

Assay IDTitleYearJournalArticle
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347168HepG2 cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347164384 well plate NINDS Rhodamine confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347155Optimization screen NINDS Rhodamine qHTS for Zika virus inhibitors: Linked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347163384 well plate NINDS AMC confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347167Vero cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347150Optimization screen NINDS AMC qHTS for Zika virus inhibitors: Linked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1578016Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) assessed as association rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1868505Inhibition of human MAO-B using p-tyramine as substrate at 100 uM by fluorimetric analysis relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1133246Inhibition of bovine adrenal medulla PNMT at 0.2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1578012Binding affinity to Pseudomonas aeruginosa tRNA (guanine(37)-N1)-methyltransferase (Leu5 to Asp25 residues) expressed in Escherichia coli BL21 (DE3) Rosetta T1R cells by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1689508Inhibition of recombinant human SET7/9 using core histone as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1192334Inhibition of SUV39H2 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID317708Inhibition of Escherichia coli DNA methyltransferase at 15 uM after 30 mins2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Activation and inhibition of DNA methyltransferases by S-adenosyl-L-homocysteine analogues.
AID1144307Inhibition of bovine adrenal medulla phenylethanolamine N-methyltransferase using 24 to 210 uM S-adenosylmethionine substrate1976Journal of medicinal chemistry, Jan, Volume: 19, Issue:1
S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations.
AID1578017Binding affinity to full length Staphylococcus aureus tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) assessed as association rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1133252Inhibition of bovine pineal gland HIOMT at 2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID424255Inhibition of human recombinant DNMT12009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors.
AID1494590Inhibition of recombinant human N-terminal FLAG-tagged PRMT5 (2 to end residues) /human N-terminal His-tagged MEP50 (2 to end residues) expressed in HEK293F cells using substrate pretreated for 15 mins followed by substrate and [3H]-SAM addition measured 2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
AID1530646Inhibition of recombinant human N-terminal FLAG-tagged PRMT5 (2 to end residues) /human N-terminal His-tagged MEP50 (2 to end residues) expressed in HEK293F cells pretreated for 15 mins followed by substrate and [3H]-SAM addition measured after 60 mins by2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
AID49929Inhibition of Catechol O-methyltransferase at 0.1 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1192328Inhibition of G9a (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1192335Inhibition of SUV420H2 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1881243Inhibition of full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM by liquid scintillation counting analysis2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1145527Inhibition of catechol O-methyltransferase (unknown origin) using 1 mM SAM as substrate at 0.6 mM1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID1868500Inhibition of EZH2 (unknown origin) using [3H]SAM and chicken core histone as substrates incubated for 1 hr2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID49930Inhibition of Catechol O-methyltransferase at 1.0 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1881236Binding affinity to full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS assessed as gibbs free energy change at 100 uM by isothermal titration calorimetry assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1133250Inhibition of bovine adrenal medulla PNMT at 2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1881241Inhibition of full length human NSUN6 expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM measured at 20 mins by liquid scintillation counting analysis2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID327643Activity of Thermotoga maritima S-adenosyl-L-homocysteine hydrolase Tm0172 assessed as homocysteine hydrolysis2007Nature, Aug-16, Volume: 448, Issue:7155
Structure-based activity prediction for an enzyme of unknown function.
AID702373Inhibition of PRMT12012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID1700196Non-competitive inhibition of C-terminal hexahistidine tag in human recombinant PNMT expressed in Escherichia coli assessed as intercept inhibition constant in presence of 5 uM PEA as substrate and AdoMet as co-substrate by Sigma-plot analysis2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
AID1133247Inhibition of guinea pig HMT at 0.2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID199295Vmax for the compound was determined against the recombinant rat liver AdoHyc hydrolase (MV1304/pUCSAH)2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Synthesis of an alpha-aminophosphonate nucleoside as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
AID1829994Binding affinity to human METTL16 assessed as change in melting temperature at 1000 uM by thermal shift assay
AID1868495Inhibition of DOTL1 (unknown origin) using [3H]SAM and HeLa oligo nucleosomes as substrates at 100 uM incubated for 1 hr relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1768049Inhibition of NSD2 (953 to 1240 residues) (unknown origin) at 30 uM using SAM as substrate in presence of nucleosome by AlphaScreen assay relative to control2021European journal of medicinal chemistry, Oct-15, Volume: 2225-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
AID424221Inhibition of human recombinant DNMT1 expressed in baculovirus infected high five insect cells2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes.
AID1624428Inhibition of DNMT1 (unknown origin) using biotinylated substrate using [3H]-SAM after 1 hr by scintillation proximity assay2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
AID1767957Inhibition of recombinant human N-terminal GST-tagged NSD2 CD (941 to 1240 residues) expressed in Escherichia coli using SAM as substrate in presence of nucleosomes by AlphaLISA method2021European journal of medicinal chemistry, Oct-15, Volume: 2225-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
AID461004Inhibition of human recombinant DNMT3B expressed in baculovirus-insect cell system by scintillation counting2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
AID631010Inhibition of human recombinant DNMT1 expressed in Sf9 cells assessed as incorporation of [3H]S-adenosyl methionine into hemimethylated oligonucleotide substrate after 3 hrs by scintillation counting2011Journal of medicinal chemistry, Nov-10, Volume: 54, Issue:21
Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
AID738916Competitive inhibition of human recombinant DOT1L (1 to 420 amino acid residues) overexpressed in Escherichia coli BL21 (DE3) using [3H]-SAM as substrate assessed as inhibition of nucleosome methylation incubated for 30 mins prior to substrate addition me2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
AID1881240Inhibition of full length recombinant human NSUN2 expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM measured at 20 mins by liquid scintillation counting analysis2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID327641Activity of Thermotoga maritima S-adenosyl-homocysteine deaminase Tm0936 assessed as ammonia production2007Nature, Aug-16, Volume: 448, Issue:7155
Structure-based activity prediction for an enzyme of unknown function.
AID1133251Inhibition of guinea pig HMT at 2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1192323Inhibition of N-terminally FLAG-tagged EZH2 Y641N mutant in EZH2/SUZ12/EED/RbAp48 complex (unknown origin) expressed in baculovirus infected in SF9 cells assessed as inhibition of methylation of nucleosomes at H3K27 by scintillation counting in presence o2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1144306Inhibition of Sprague-Dawley rat liver catechol O-methyltransferase using 24 to 210 uM S-adenosylmethionine substrate1976Journal of medicinal chemistry, Jan, Volume: 19, Issue:1
S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations.
AID424222Inhibition of human recombinant DNMT3b2 expressed in baculovirus infected high five insect cells2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes.
AID317709Inhibition of M.HhaI DNA methyltransferase expressed in ER1727 cells at 15 uM after 30 mins2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Activation and inhibition of DNA methyltransferases by S-adenosyl-L-homocysteine analogues.
AID702365Binding affinity at human recombinant DOT1L catalytic domain amino acid (1 to 472) by isothermal titration calorimetric assay2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID1881242Inhibition of recombinant human EHMT2 G9a expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM using histone H3 as substrate measured at 120 mins by liquid scintillation counting analysis2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID631009Inhibition of human recombinant DNMT1 expressed in Sf9 cells assessed as remaining activity at 2 mM after 3 hrs by scintillation counting in presence of [3H]S-adenosyl methionine2011Journal of medicinal chemistry, Nov-10, Volume: 54, Issue:21
Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
AID155165Inhibition of PNMT at 0.1 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1192331Inhibition of SETD7 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1226184Inhibition of human full length DNMT3A expressed in Sf9 cells2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Discovery of a Dual PRMT5-PRMT7 Inhibitor.
AID657292Inhibition of Yersinia pestis Dam using oligonucleotide 1 as substrate after 2000 to 3000 sec by micro plate reader based real-time break-light assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Development of rationally designed DNA N6 adenine methyltransferase inhibitors.
AID1145525Inhibition of catechol O-methyltransferase (unknown origin) using 1 mM SAM as substrate at 0.1 mM1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID90044Inhibition constant was evaluated against Histamine N-methyl-transferase1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1192336Inhibition of SMYD2 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1689505Inhibition of recombinant human DNMT1 using poly(dl-dC) as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1636911Inhibition of PRMT3 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID738930Competitive inhibition of human recombinant DOT1L (1 to 472 amino acid residues) expressed in Escherichia coli BL21 (DE3) using [3H]-SAM assessed as inhibition of nucleosome methylation incubated for 10 mins prior to substrate addition measured after 30 m2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
AID1133262Retardation factor, Rf of the compound on silica gel GF containing EtOH-HOAc-H2O (20:2:2)/0.1 M phosphate buffer at 7.4 by chromatography1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1700192Competitive inhibition of C-terminal hexahistidine tag in human recombinant PNMT expressed in Escherichia coli assessed as inhibition constant using PEA as substrate in presence of 100 uM AdoMet as co-substrate by Sigma-plot analysis2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
AID1636910Inhibition of DNMT1 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1510774Inhibition of wild-type human full length NNMT expressed in Escherichia coli BL21(DE3) cells assessed as reduction in 1-methyl-nicotinamide formation pre-incubated for 10 mins followed by AdoMet and nicotinamide addition measured after 30 mins by UHP-HILI2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Bisubstrate Inhibitors of Nicotinamide
AID90042Inhibition of Histamine N-methyl-transferase at 0.1 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1868504Inhibition of human MAO-A using p-tyramine as substrate by fluorimetric analysis2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1578019Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) assessed as dissociation rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1689509Inhibition of recombinant human PRMT3 using histone H4 as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1689506Inhibition of recombinant human EZH2 using core histone as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID90043Inhibition of Histamine N-methyl-transferase at 1.0 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1192333Inhibition of SUV39H1 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID155166Inhibition of PNMT at 1.0 mM1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1054112Competitive inhibition of recombinant human DOT1L using adenosine/deazaadenosine as substrate and SAM cofactor2013Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22
A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.
AID1226182Inhibition of human full length PRMT5 expressed in Sf9 cells2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Discovery of a Dual PRMT5-PRMT7 Inhibitor.
AID1700195Selectivity index, ratio of Ki for alpha2 adrenergic receptor in Sprague-dawley rat to Ki for competitive inhibition of C-terminal hexahistidine tag in human recombinant PNMT expressed in Escherichia coli in presence of PEA as substrate and AdoMet as co-s2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
AID1226183Inhibition of human full length PRMT7 expressed in Sf9 cells2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Discovery of a Dual PRMT5-PRMT7 Inhibitor.
AID1226185Inhibition of human full length DNMT3B expressed in Sf9 cells2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Discovery of a Dual PRMT5-PRMT7 Inhibitor.
AID70365Inhibition of ErmAM methylase2000Bioorganic & medicinal chemistry letters, Mar-06, Volume: 10, Issue:5
Design and synthesis of mimics of S-adenosyl-L-homocysteine as potential inhibitors of erythromycin methyltransferases.
AID1133249Inhibition of Sprague-Dawley rat liver COMT at 2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1636915Inhibition of SUV39H2 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID155171Inhibition constant was evaluated against PNMT1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
AID1689511Inhibition of recombinant human PRMT7 using GST-GAR as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1133248Inhibition of bovine pineal gland HIOMT at 0.2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID424256Inhibition of human recombinant DNMT3b22009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors.
AID1636912Inhibition of PRMT5 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1464543Inhibition of recombinant human N-terminal GST-tagged PRMT1 (2 to end residues) expressed in baculovirus infected Sf9 insect cells at 9 uM using biotinylated histone H4 peptide as substrate preincubated for 15 mins followed by substrate/[3H]-SAM addition 2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
AID1054111Inhibition of CARM1 (unknown origin)2013Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22
A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.
AID1689512Inhibition of recombinant human PRMT8 using histone H4 as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1145530Inhibition of tRNA-methyltransferase (unknown origin) using 0.1 mM SAM and 40 ug tRNA as substrate at 0.2 mM1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID1145532Inhibition of tRNA-methyltransferase (unknown origin) using 0.1 mM SAM and 40 ug tRNA as substrate by Dixon plot analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID1578020Binding affinity to full length Staphylococcus aureus tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) assessed as dissociation rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1624436Binding affinity to DNMT3A/3L (unknown origin) assessed as active protein binding by SPR assay2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
AID1829995Binding affinity to human METTL1 assessed as change in melting temperature at 1000 uM by thermal shift assay
AID1578022Binding affinity to Pseudomonas aeruginosa tRNA (guanine(37)-N1)-methyltransferase (Leu5 to Asp25 residues) expressed in Escherichia coli BL21 (DE3) Rosetta T1R cells assessed as thermal stabilization of protein by measuring change in melting temperature 2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID91847Inhibitory constant towards indole N-methyl-transferase1983Journal of medicinal chemistry, Oct, Volume: 26, Issue:10
Multisubstrate adducts as potential inhibitors of S-adenosylmethionine dependent methylases: inhibition of indole N-methyltransferase by (5'-deoxyadenosyl)[3-(3-indolyl)prop-1-yl]methylsulfonium and (5'-deoxyadenosyl)[4-(3-indolyl)but-1-yl]methylsulfonium
AID70364Inhibitory activity against ErmAM methylase1999Journal of medicinal chemistry, Sep-23, Volume: 42, Issue:19
Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis.
AID1882673Inhibition of human C-terminal domain DNMT3b catalytic domain (568 to 853 residues) expressed in Escherichia coli BL21 (DE3) pLysS cells assessed as inhibition of methylated dI-dC formation using poly dI-dC and [Me-3H]SAM as substrate incubated for 45 min2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1.
AID327642Ratio of Kcat to Km for Thermotoga maritima S-adenosyl-homocysteine deaminase Tm0936 assessed as ammonia production2007Nature, Aug-16, Volume: 448, Issue:7155
Structure-based activity prediction for an enzyme of unknown function.
AID702374Inhibition of human recombinant DOT1L catalytic domain amino acid (1 to 472) using [3H]-SAM after 30 mins by scintillation counter2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID1882663Inhibition of human recombinant full-length DNMT1 expressed in Sf9 cells assessed as inhibition of methylated dI-dC formation using poly dI-dC and [Me-3H]SAM as substrate incubated for 2 hrs by liquid scintillation counting analysis2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1.
AID1192329Inhibition of EHMT1 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID702364Binding affinity at human recombinant DOT1L catalytic domain amino acid (1 to 472)-nucleosome complex by isothermal titration calorimetric assay2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID1525536Inhibition of DOT1-like Histone H3 Methyltransferase (unknown origin)2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
Why Some Targets Benefit from beyond Rule of Five Drugs.
AID1881238Binding affinity to full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS assessed as change in entropy at 100 uM by isothermal titration calorimetry assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1829989Inhibition of recombinant METLL3 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in N6-methyladenosine level in oligonucleotide substrate by TR-FRET assay
AID1054110Inhibition of G9a (unknown origin)2013Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22
A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.
AID199294Km for the compound was determined against the recombinant rat liver AdoHyc hydrolase (MV1304/pUCSAH)2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Synthesis of an alpha-aminophosphonate nucleoside as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
AID702371Inhibition of CARM12012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID1578024Binding affinity to Pseudomonas aeruginosa tRNA (guanine(37)-N1)-methyltransferase (Leu5 to Asp25 residues) expressed in Escherichia coli BL21 (DE3) Rosetta T1R cells assessed as thermal stabilization of protein by measuring melting temperature at 2 mM by2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1881233Binding affinity to full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS assessed as dissociation constant at 100 uM by isothermal titration calorimetry assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1868499Inhibition of EZH2 (unknown origin) using [3H]SAM and chicken core histone as substrates at 100 uM incubated for 1 hr relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID327644Ratio of Kcat to Km for Thermotoga maritima S-adenosyl-L-homocysteine hydrolase Tm0172 assessed as homocysteine hydrolysis2007Nature, Aug-16, Volume: 448, Issue:7155
Structure-based activity prediction for an enzyme of unknown function.
AID1145529Inhibition of tRNA-methyltransferase (unknown origin) using 0.1 mM SAM and 40 ug tRNA as substrate at 0.1 mM1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID1636909Inhibition of human recombinant DOT1L (1 to 420 amino acids) expressed in Escherichia coli2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1631411Inhibition of Dengue virus ribose 2'-O methyltransferase using RNA substrate after 20 mins in presence of [methyl-3H]-AdoMet by microbeta counting analysis2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
The Medicinal Chemistry of Dengue Virus.
AID1510775Inhibition of wild-type human full length NNMT expressed in Escherichia coli BL21(DE3) cells assessed as reduction in 1-methyl-nicotinamide formation at 250 uM pre-incubated for 10 mins followed by AdoMet and nicotinamide addition measured after 30 mins b2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Bisubstrate Inhibitors of Nicotinamide
AID1868503Inhibition of human MAO-A using p-tyramine as substrate at 100 uM by fluorimetric analysis relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1169761Inhibition of N-terminal His6-tagged mouse DNMT1 (731 to 1602 residues) at 200 uM expressed in Escherichia coli BL21 (DE3) incubated for 2 hrs using S-adenosylmethionine by ELISA2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
AID1192332Inhibition of SETDB1 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1829993Binding affinity to human METTL3/METLL14 assessed as change in melting temperature at 1000 uM by thermal shift assay
AID27157Apparent kinetic activity measured for protein carboxyl methyltransferase in Leishmania donovani promastigotes1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Synthesis and biological activity of sinefungin analogues.
AID1192326Inhibition of EZH1 (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID657294Selectivity ratio of IC50 for human Dnmt1 to IC50 for Yersinia pestis Dam2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Development of rationally designed DNA N6 adenine methyltransferase inhibitors.
AID1133245Inhibition of Sprague-Dawley rat liver COMT at 0.2 mM by radiochemical technique1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1145526Inhibition of catechol O-methyltransferase (unknown origin) using 1 mM SAM as substrate at 0.2 mM1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.
AID1192321Inhibition of N-terminally FLAG-tagged wild type EZH2 in EZH2/SUZ12/EED/RbAp48 complex (unknown origin) expressed in baculovirus infected in SF9 cells assessed as inhibition of methylation of nucleosomes at H3K27 by scintillation counting in presence of [2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1144308Inhibition of guinea pig brain histamine N-methyltransferase using 24 to 210 uM S-adenosylmethionine substrate1976Journal of medicinal chemistry, Jan, Volume: 19, Issue:1
S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations.
AID1636914Inhibition of SETD7 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1868506Inhibition of human MAO-B using p-tyramine as substrate by fluorimetric analysis2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1196391Displacement of [3H]-SAM from recombinant His6-tagged PRMT1 (unknown origin) expressed in Escherichia coli BL21(DE3) incubated for 5 mins prior to H4(1 to 20)-BTN peptide addition measured after 8 mins by scintillation proximity assay2015Journal of medicinal chemistry, Feb-12, Volume: 58, Issue:3
Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.
AID461003Inhibition of human recombinant DNMT1 expressed in baculovirus-insect cell system by scintillation counting2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
AID1868498Inhibition of SETD8 (unknown origin) using [3H]SAM and HeLa nucleosomes as substrates incubated for 1 hr2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID702372Inhibition of SUV39H12012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
AID670021Inhibition of full length N-terminal His6-tagged human DNMT1 after 1 hr by fluorescence analysis2012Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
AID1192330Inhibition of MLL (unknown origin) by HMT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1868501Inhibition of PRMT1 (unknown origin) using [3H]SAM and chicken histone 4 as substrates at 100 uM incubated for 1 hr relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID613026Binding affinity to 2-amino purine labelled SAM2 riboswitch aptamer assessed as change in fluorescence at 5 mM to 10 mM at pH 8.3 by fluorescence binding assay2011Bioorganic & medicinal chemistry letters, Sep-01, Volume: 21, Issue:17
Rational design of SAM analogues targeting SAM-II riboswitch aptamer.
AID461001Inhibition of human recombinant DNMT1 expressed in baculovirus-insect cell system at 100 uM by scintillation counting2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
AID1636916Inhibition of EZH2 (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1881237Binding affinity to full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS assessed as change in enthalpy change at 100 uM by isothermal titration calorimetry assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID230419It is the ratio of Ki value to that of Km.1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Synthesis and biological activity of sinefungin analogues.
AID1868496Inhibition of DOTL1 (unknown origin) using [3H]SAM and HeLa oligo nucleosomes as substrates incubated for 1 hr2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1881234Inhibition of full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS by isothermal titration calorimetry assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1631410Inhibition of Dengue virus guanine N-7 methyltransferase using RNA substrate after 20 mins in presence of [methyl-3H]-AdoMet by microbeta counting analysis2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
The Medicinal Chemistry of Dengue Virus.
AID1578018Binding affinity to Pseudomonas aeruginosa tRNA (guanine(37)-N1)-methyltransferase (Leu5 to Asp25 residues) expressed in Escherichia coli BL21 (DE3) Rosetta T1R cells assessed as dissociation rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1700194Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
AID461002Inhibition of human recombinant DNMT3B expressed in baculovirus-insect cell system at 100 uM by scintillation counting2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
AID1578014Binding affinity to full length Staphylococcus aureus tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1578027Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) assessed as thermal stabilization of protein by measuring melting temperature at 2 mM by SYPRO orange based thermal2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1578015Binding affinity to Pseudomonas aeruginosa tRNA (guanine(37)-N1)-methyltransferase (Leu5 to Asp25 residues) expressed in Escherichia coli BL21 (DE3) Rosetta T1R cells assessed as association rate constant by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1881232Inhibition of full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM using tRNA asp as substrate and SAM as co-substrate incubated for 5 mins by tritium incorporation assay relative to control2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1868502Inhibition of PRMT1 (unknown origin) using [3H]SAM and chicken histone 4 as substrates incubated for 1 hr2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1636913Inhibition of G9a (unknown origin)2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
AID1868497Inhibition of SETD8 (unknown origin) using [3H]SAM and HeLa nucleosomes as substrates at 100 uM incubated for 1 hr relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
AID1464544Inhibition of recombinant human N-terminal GST-tagged PRMT1 (2 to end residues) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H4 peptide as substrate preincubated for 15 mins followed by substrate/[3H]-SAM addition measured2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
AID71601Inhibition constant against Escherichia coli cyclopropane fatty acid synthase2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Synthesis and evaluation of analogues of S-adenosyl-L-methionine, as inhibitors of the E. coli cyclopropane fatty acid synthase.
AID1255952Inhibition of PRMT1 (unknown origin) using biotinylated histone H4-derived peptide as substrate after 60 mins by AlphaLISA assay2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
AID1133261Retardation factor, Rf of the compound on silica gel GF containing 5% Na2HPO4 by chromatography1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 7. Role of the ribosyl moiety in enzymatic binding of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine.
AID1658842Inhibition of recombinant human MLL1 complex (MLL1/Ash2L/RbBP5/WDR5/DPY-30) expressed in Escherichia coli Rosetta 2 (DE3) cells using H3 (1 to 21) peptide as substrate incubated for 1 hr in presence of 3[H] SAM by AlphaLISA assay2020ACS medicinal chemistry letters, Jun-11, Volume: 11, Issue:6
Discovery of Potent Small-Molecule Inhibitors of MLL Methyltransferase.
AID1144309Inhibition of bovine pineal gland hydroxyindole O-methyltransferase using 24 to 210 uM S-adenosylmethionine substrate1976Journal of medicinal chemistry, Jan, Volume: 19, Issue:1
S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations.
AID1072835Inhibition of N-terminal GST-tagged recombinant human Histone-lysine N-methyltransferase G9a using S-(5'-adenosyl)-L-methionine chloride as substrate assessed as nonspecific denaturation of enzyme at 0.05 to 25 uM preincubated for 30 mins in presence of u2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
On the histone lysine methyltransferase activity of fungal metabolite chaetocin.
AID1881231Binding affinity to full length human N-terminal his6-tagged DNMT2 expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM incubated for 5 mins by microscale thermophoresis assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID670019Inhibition of full length N-terminal His6-tagged human DNMT1 at 30 uM after 1 hr by fluorescence analysis2012Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
AID1881239Inhibition of recombinant human DNMT3A-3L expressed in Escherichia coli Rosetta2(DE3)pLysS at 100 uM using Poly(dI-dC)-Poly(dI-dC) as substrate measured at 150 mins by liquid scintillation counting analysis2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
AID1192324Inhibition of EZH2 (unknown origin) at 100 uM by cell-based assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
SAH derived potent and selective EZH2 inhibitors.
AID1578013Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-
AID1700193Non-competitive inhibition of C-terminal hexahistidine tag in human recombinant PNMT expressed in Escherichia coli assessed as slope inhibition constant in presence of 5 uM PEA as substrate and AdoMet as co-substrate by Sigma-plot analysis2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
AID1689507Inhibition of recombinant human G9a using histone H3 (1 to 21) as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1689510Inhibition of recombinant human PRMT5 using histone H2A as substrate by hotspot assay2020European journal of medicinal chemistry, Mar-01, Volume: 189Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
AID1739793Binding affinity to SARS-CoV nsp14 assessed as increase in melting temperature at 1 mM at pH 7.5 by differential scanning fluorimetry2020European journal of medicinal chemistry, Sep-01, Volume: 201Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
AID657293Inhibition of human Dnmt1 using oligonucleotide 2 as substrate after 5000 sec by micro plate reader based real-time break-light assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Development of rationally designed DNA N6 adenine methyltransferase inhibitors.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2004Journal of molecular biology, Nov-19, Volume: 344, Issue:2
Structure/function studies on a S-adenosyl-L-methionine-dependent uroporphyrinogen III C methyltransferase (SUMT), a key regulatory enzyme of tetrapyrrole biosynthesis.
AID1811Experimentally measured binding affinity data derived from PDB2004Journal of molecular biology, Nov-19, Volume: 344, Issue:2
Structure/function studies on a S-adenosyl-L-methionine-dependent uroporphyrinogen III C methyltransferase (SUMT), a key regulatory enzyme of tetrapyrrole biosynthesis.
AID1811Experimentally measured binding affinity data derived from PDB2003The Journal of biological chemistry, Jul-11, Volume: 278, Issue:28
Structures of liganded and unliganded RsrI N6-adenine DNA methyltransferase: a distinct orientation for active cofactor binding.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2003The Journal of biological chemistry, Jul-11, Volume: 278, Issue:28
Structures of liganded and unliganded RsrI N6-adenine DNA methyltransferase: a distinct orientation for active cofactor binding.
AID1811Experimentally measured binding affinity data derived from PDB1999Journal of molecular biology, Jun-04, Volume: 289, Issue:2
The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1999Journal of molecular biology, Jun-04, Volume: 289, Issue:2
The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism.
AID1347158ZIKV-mCherry secondary qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347156DAPI mCherry counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1997Journal of molecular biology, Jan-10, Volume: 265, Issue:1
Differential binding of S-adenosylmethionine S-adenosylhomocysteine and Sinefungin to the adenine-specific DNA methyltransferase M.TaqI.
AID1811Experimentally measured binding affinity data derived from PDB1997Journal of molecular biology, Jan-10, Volume: 265, Issue:1
Differential binding of S-adenosylmethionine S-adenosylhomocysteine and Sinefungin to the adenine-specific DNA methyltransferase M.TaqI.
AID1811Experimentally measured binding affinity data derived from PDB2001Structure (London, England : 1993), Sep, Volume: 9, Issue:9
Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2001Structure (London, England : 1993), Sep, Volume: 9, Issue:9
Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2006The Journal of biological chemistry, Jul-14, Volume: 281, Issue:28
Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,385)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990407 (29.39)18.7374
1990's206 (14.87)18.2507
2000's358 (25.85)29.6817
2010's355 (25.63)24.3611
2020's59 (4.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.07 (24.57)
Research Supply Index7.27 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index78.13 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials20 (1.42%)5.53%
Reviews58 (4.11%)6.00%
Case Studies5 (0.35%)4.05%
Observational1 (0.07%)0.25%
Other1,328 (94.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]